Pompe disease, also called acid maltase deficiency or type II glycogen storage disease, is a rare, autosomal recessive, but lethal metabolic myopathy caused by mutations in the gene coding for acid alpha-glucosidase (GAA), the enzyme that decomposes glycogen in the lysosome (Kohler et al., 2018). This evidence concerns the gene GAA and Glycogen storage disease due to glycogenin deficiency.